Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 26.14% is 192% above its 5-year average of 8.96%, near the high end of its 5-year range (-318.74%–75.09%).
3.57% below its 12-month average of 27.11%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-28): 27.18%.
EBITDA MARGIN
26.14%
EBITDA MARGIN AVG TTM
27.11%
EBITDA MARGIN AVG 3Y
18.11%
EBITDA MARGIN AVG 5Y
8.96%
EBITDA MARGIN AVG 10Y
23.33%
EBITDA MARGIN AVG 15Y
27.06%
EBITDA MARGIN AVG 20Y
26.16%
CURRENT VS TTM AVG
-3.57%
CURRENT VS 3Y AVG
+44.34%
CURRENT VS 5Y AVG
+191.70%
CURRENT VS 10Y AVG
+12.05%
CURRENT VS 15Y AVG
-3.40%
CURRENT VS 20Y AVG
-0.07%
Market Cap
$40.89B
EBITDA Margin
34.08%
TTM Avg
33.18%
3Y Avg
32.37%
5Y Avg
31.82%
Market Cap
$41.75B
EBITDA Margin
34.73%
TTM Avg
34.58%
3Y Avg
34.05%
5Y Avg
33.84%
Market Cap
$42.50B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
Market Cap
$46.04B
EBITDA Margin
18.31%
TTM Avg
11.44%
3Y Avg
6.73%
5Y Avg
5.67%
Market Cap
$47.38B
EBITDA Margin
25.43%
TTM Avg
26.12%
3Y Avg
26.05%
5Y Avg
25.37%
Market Cap
$48.72B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$49.03B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 26.14% | 27.11% | 18.11% | 8.96% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 34.08% | 33.18% | 32.37% | 31.82% |
| Waters Corporation (WAT)vs › | $41.75B | 34.73% | 34.58% | 34.05% | 33.84% |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 21.04% | 21.29% | 20.90% | 20.09% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 18.31% | 11.44% | 6.73% | 5.67% |
| Humana Inc. (HUM)vs › | $46.63B | 1.76% | 1.98% | 3.17% | 4.08% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 25.43% | 26.12% | 26.05% | 25.37% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 23.08% | 23.14% | 23.23% | 22.53% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 29.55% | 28.88% | 30.96% | 31.73% |
| Biogen Inc. (BIIB)vs › | $32.49B | 28.67% | 30.68% | 30.30% | 31.44% |
Gross Margin
66.8%
EBITDA Margin
26.1%
Operating Margin
21.0%
Net Margin
18.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-28 | 27.18% |
| 2026-03-29 | 25.48% |
| 2025-12-28 | 27.93% |
| 2025-09-28 | 27.52% |
| 2025-06-29 | 27.44% |
| 2025-03-30 | 24.30% |
| 2024-12-29 | 24.73% |
| 2024-09-29 | 75.09% |
| 2024-06-30 | -137.77% |
| 2024-03-31 | -0.28% |
| 2023-12-31 | -4.90% |
| 2023-10-01 | -57.73% |
| 2023-07-02 | 1.70% |
| 2023-04-02 | 3.96% |
| 2022-12-31 | -1.94% |
| 2022-10-02 | -318.74% |
| 2022-07-03 | -41.74% |
| 2022-04-03 | 22.49% |
| 2021-12-31 | 10.84% |
| 2021-10-03 | -43.32% |
| 2021-07-04 | 20.96% |
| 2021-04-04 | 22.05% |
| 2020-12-31 | 19.20% |
| 2020-09-27 | 26.32% |
| 2020-06-28 | 22.43% |
| 2020-03-29 | 27.12% |
| 2019-12-31 | 32.88% |
| 2019-09-29 | 39.14% |
| 2019-06-30 | 30.31% |
| 2019-03-31 | 29.67% |
| 2018-12-31 | 28.49% |
| 2018-09-30 | 33.53% |
| 2018-07-01 | 32.77% |
| 2018-04-01 | 32.86% |
| 2017-12-31 | 34.58% |
| 2017-10-01 | 31.09% |
| 2017-07-02 | 27.34% |
| 2017-04-02 | 15.05% |
| 2016-12-31 | 29.14% |
| 2016-10-02 | 32.45% |
| 2016-07-03 | 32.66% |
| 2016-04-03 | 26.93% |
| 2015-12-31 | 29.88% |
| 2015-09-27 | 31.55% |
| 2015-06-28 | 33.86% |
| 2015-03-29 | 38.29% |
| 2014-12-31 | 45.44% |
| 2014-09-28 | 30.41% |
| 2014-06-29 | 28.55% |
| 2014-03-30 | 28.64% |
| 2013-12-31 | 26.06% |
| 2013-09-29 | 20.28% |
| 2013-06-30 | 24.08% |
| 2013-03-31 | -7.44% |
| 2012-12-31 | 25.04% |
| 2012-09-30 | 22.77% |
| 2012-07-01 | 20.66% |
| 2012-04-01 | 23.84% |
| 2011-12-31 | 18.30% |
| 2011-10-02 | 23.04% |
| 2011-07-03 | 28.70% |
| 2011-04-03 | 30.16% |
| 2010-12-31 | 30.83% |
| 2010-10-03 | 28.84% |
| 2010-07-04 | 27.09% |
| 2010-04-04 | 24.59% |
| 2009-12-31 | 18.61% |
| 2009-09-27 | 23.69% |
| 2009-06-28 | 27.15% |
| 2009-03-29 | 25.21% |
| 2008-12-31 | 27.97% |
| 2008-09-28 | 5.40% |
| 2008-06-29 | 21.97% |
| 2008-03-30 | 20.89% |
| 2007-12-31 | -25.36% |
| 2007-09-30 | 18.24% |
| 2007-07-01 | 19.15% |
| 2007-04-01 | -405.31% |
| 2006-12-31 | 30.36% |
| 2006-10-01 | 31.45% |
| 2006-07-02 | 18.97% |
| 2006-04-02 | 1.60% |
| 2005-12-31 | 6.36% |
| 2005-10-02 | -3.44% |
| 2005-07-03 | -112.73% |
| 2005-04-03 | -4.09% |
| 2004-12-31 | 25.90% |
| 2004-10-03 | -5.15% |
| 2004-06-27 | -16.54% |
| 2004-03-28 | -16.18% |
| 2003-12-31 | -20.24% |
| 2003-09-28 | -43.65% |
| 2003-06-29 | -136.55% |
| 2003-03-30 | -161.46% |
| 2002-12-31 | -2059.65% |
| 2002-09-29 | 463.28% |
